Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics.

Tytuł:
The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics.
Autorzy:
Li H; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Xia P; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Pan S; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Qi Z; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Fu C; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Yu Z; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Kong W; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Chang Y; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Wang K; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Wu D; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Yang X; Department of Orthopedic Surgery, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China.
Źródło:
International journal of nanomedicine [Int J Nanomedicine] 2020 Sep 29; Vol. 15, pp. 7199-7214. Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Auckland : DOVE Medical Press,
MeSH Terms:
Biomedical Technology*
Orthopedics*
Cerium/*chemistry
Nanoparticles/*chemistry
Humans ; Nanotechnology ; Prostheses and Implants
References:
Antioxidants (Basel). 2018 Jul 24;7(8):. (PMID: 30042320)
J Photochem Photobiol B. 2020 Jan;202:111706. (PMID: 31775112)
Int J Nanomedicine. 2017 Feb 20;12:1401-1413. (PMID: 28260887)
ACS Omega. 2020 Apr 26;5(17):9714-9723. (PMID: 32391458)
Int J Nanomedicine. 2016 Dec 07;11:6507-6516. (PMID: 27994456)
Appl Biochem Biotechnol. 2016 Oct;180(4):638-654. (PMID: 27234032)
Biomolecules. 2019 Oct 03;9(10):. (PMID: 31623336)
Acta Biomater. 2017 Mar 1;50:127-141. (PMID: 27940194)
ACS Appl Mater Interfaces. 2020 Apr 15;12(15):17745-17751. (PMID: 32250100)
J Int Soc Prev Community Dent. 2015 May-Jun;5(3):147-56. (PMID: 26236672)
J Nanosci Nanotechnol. 2011 Jan;11(1):125-30. (PMID: 21446415)
Biofabrication. 2019 Mar 28;11(2):025012. (PMID: 30754024)
Int J Mol Sci. 2013 Feb 01;14(2):3065-77. (PMID: 23377016)
Chem Soc Rev. 2013 Jul 21;42(14):6060-93. (PMID: 23740388)
Toxicol Ind Health. 2020 Feb;36(2):76-83. (PMID: 32279649)
Dent Mater J. 2015;34(5):692-701. (PMID: 26438994)
ACS Appl Mater Interfaces. 2019 Jan 9;11(1):195-201. (PMID: 30556997)
Acta Biomater. 2019 Aug;94:627-643. (PMID: 31212111)
Int J Nanomedicine. 2020 Apr 15;15:2515-2527. (PMID: 32368038)
Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):3923-30. (PMID: 23910297)
Environ Sci Nano. 2015 Feb 1;2(1):33-53. (PMID: 26207185)
Adv Mater. 2019 May;31(19):e1807965. (PMID: 30920695)
Sci Rep. 2018 May 3;8(1):6999. (PMID: 29725117)
Nanomaterials (Basel). 2018 May 24;8(6):. (PMID: 29794997)
Nanotechnology. 2020 Jul 31;31(31):315708. (PMID: 32268308)
Biomed Mater. 2015 Sep 21;10(5):055008. (PMID: 26391473)
RSC Adv. 2023 Mar 29;13(15):10016. (PMID: 37011254)
J Nanosci Nanotechnol. 2020 Jul 1;20(7):3971-3980. (PMID: 31968410)
Int J Biol Macromol. 2017 Nov;104(Pt B):1746-1752. (PMID: 28359891)
Mater Sci Eng C Mater Biol Appl. 2018 Jul 1;88:13-24. (PMID: 29636127)
Nanoscale. 2011 Apr;3(4):1411-20. (PMID: 21369578)
Environ Sci Pollut Res Int. 2020 Aug;27(24):30479-30489. (PMID: 32468358)
Bioengineering (Basel). 2020 Mar 13;7(1):. (PMID: 32183157)
ACS Appl Mater Interfaces. 2016 Feb;8(7):4489-99. (PMID: 26824825)
Nanomaterials (Basel). 2020 Jan 29;10(2):. (PMID: 32013189)
J Mech Behav Biomed Mater. 2020 Aug;108:103782. (PMID: 32469715)
Mol Pharm. 2018 Mar 5;15(3):994-1004. (PMID: 29397735)
Chem Commun (Camb). 2010 Apr 28;46(16):2736-8. (PMID: 20369166)
Colloids Surf B Biointerfaces. 2019 Sep 1;181:830-836. (PMID: 31252219)
Adv Drug Deliv Rev. 2008 Feb 14;60(3):299-327. (PMID: 18192071)
Adv Healthc Mater. 2019 May;8(9):e1801548. (PMID: 30843374)
J Biochem Mol Toxicol. 2020 Jun;34(6):e22475. (PMID: 32053270)
Materials (Basel). 2017 Jun 03;10(6):. (PMID: 28772973)
Nanomaterials (Basel). 2017 Sep 16;7(9):. (PMID: 28926967)
Nanomaterials (Basel). 2019 Nov 04;9(11):. (PMID: 31690040)
Acta Biomater. 2020 Jun;109:1-20. (PMID: 32268239)
Materials (Basel). 2020 May 15;13(10):. (PMID: 32429291)
J Mater Sci Mater Med. 2016 Jun;27(6):100. (PMID: 27091042)
J Biomed Mater Res A. 2015 Jan;103(1):8-15. (PMID: 24677427)
Angew Chem Int Ed Engl. 2004 Nov 12;43(44):5980-4. (PMID: 15547911)
J Mater Chem B. 2017 Dec 21;5(47):9371-9383. (PMID: 32264540)
Int J Biol Macromol. 2020 Jun 15;153:806-816. (PMID: 32145236)
ACS Appl Mater Interfaces. 2020 May 20;12(20):22410-22425. (PMID: 32349479)
Turk J Med Sci. 2020 Apr 27;50(SI-2):1707-1722. (PMID: 32336073)
Acta Biomater. 2013 Jan;9(1):4836-44. (PMID: 23026489)
Int J Oral Maxillofac Implants. 2017 Jan/Feb;32(1):81-91. (PMID: 28095516)
Adv Sci (Weinh). 2017 Dec 18;5(2):1700678. (PMID: 29610729)
J Biomed Mater Res A. 2006 Sep 15;78(4):693-701. (PMID: 16739176)
ACS Biomater Sci Eng. 2015 Nov 9;1(11):1096-1103. (PMID: 33429551)
Int J Clin Exp Pathol. 2014 Jul 15;7(8):5369-78. (PMID: 25197425)
J Biomater Appl. 2017 Feb;31(7):1062-1076. (PMID: 27932702)
J Prosthodont Res. 2018 Apr;62(2):121-133. (PMID: 28827030)
Int J Environ Res Public Health. 2015 Jan 23;12(2):1253-78. (PMID: 25625406)
Addit Manuf. 2020 Aug;34:. (PMID: 32432027)
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S956-S963. (PMID: 30314412)
Biomater Sci. 2019 May 28;7(6):2533-2544. (PMID: 30968875)
Int J Mol Sci. 2020 Apr 05;21(7):. (PMID: 32260477)
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110851. (PMID: 32279772)
Biol Trace Elem Res. 2018 Mar;182(1):91-104. (PMID: 28624869)
J Mater Chem B. 2020 May 14;8(18):4016-4028. (PMID: 32347289)
Nanomaterials (Basel). 2019 Nov 29;9(12):. (PMID: 31795404)
Biosens Bioelectron. 2017 Mar 15;89(Pt 1):681-688. (PMID: 26617189)
Biol Trace Elem Res. 2017 Oct;179(2):259-270. (PMID: 28229387)
J Trace Elem Med Biol. 2019 Mar;52:126-135. (PMID: 30732873)
Chem Sci. 2020 Feb 5;11(10):2796-2809. (PMID: 34084340)
J Biol Eng. 2020 May 6;14:14. (PMID: 32391080)
J Nanosci Nanotechnol. 2019 Jul 1;19(7):3964-3970. (PMID: 30764957)
Drug Metab Rev. 2019 Nov;51(4):533-544. (PMID: 31577468)
J Nanobiotechnology. 2019 Jul 10;17(1):84. (PMID: 31291944)
FASEB J. 2019 May;33(5):6378-6389. (PMID: 30776318)
Nanomedicine (Lond). 2018 Dec;13(23):3051-3069. (PMID: 30507347)
Contributed Indexing:
Keywords: CeO2-NPs; ROS; bone tissue engineering; coating; green synthesis; orthopedic implants
Substance Nomenclature:
30K4522N6T (Cerium)
619G5K328Y (ceric oxide)
Entry Date(s):
Date Created: 20201016 Date Completed: 20201106 Latest Revision: 20240329
Update Code:
20240329
PubMed Central ID:
PMC7535115
DOI:
10.2147/IJN.S270229
PMID:
33061376
Czasopismo naukowe
The ongoing biomedical nanotechnology has intrigued increasingly intense interests in cerium oxide nanoparticles, ceria nanoparticles or nano-ceria (CeO 2 -NPs). Their remarkable vacancy-oxygen defect (VO) facilitates the redox process and catalytic activity. The verification has illustrated that CeO 2 -NPs, a nanozyme based on inorganic nanoparticles, can achieve the anti-inflammatory effect, cancer resistance, and angiogenesis. Also, they can well complement other materials in tissue engineering (TE). Pertinent to the properties of CeO 2 -NPs and the pragmatic biosynthesis methods, this review will emphasize the recent application of CeO 2 -NPs to orthopedic biomedicine, in particular, the bone tissue engineering (BTE). The presentation, assessment, and outlook of the orthopedic potential and shortcomings of CeO 2 -NPs in this review expect to provide reference values for the future research and development of therapeutic agents based on CeO 2 -NPs.
Competing Interests: The authors report no conflicts of interest in this work.
(© 2020 Li et al.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies